This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Universitât Bern. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kris Meier - Innovator in Janus Kinase Inhibitors
Introduction
Kris Meier is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as Janus kinase (JAK) inhibitors. His work is crucial in the ongoing search for effective treatments for various diseases.
Latest Patents
Kris Meier holds a patent for "Substituted cyclopenta[2,1-b:5,1-b']dipyrroles as Janus kinase (JAK) inhibitors." This invention relates to compounds of formula 1 or 2, which have potential therapeutic applications. The patent highlights the innovative nature of his work and its relevance in the pharmaceutical industry.
Career Highlights
Kris Meier is affiliated with Universität Bern, where he conducts research and collaborates with other scientists. His academic background and research focus have positioned him as a key figure in his field. His contributions have been recognized through his patent, which underscores his expertise and innovative spirit.
Collaborations
Kris Meier has worked alongside Jean-Louis Reymond, a fellow researcher. Their collaboration has likely enhanced the quality and impact of their research efforts, leading to advancements in the understanding of JAK inhibitors.
Conclusion
Kris Meier's work in developing Janus kinase inhibitors represents a significant advancement in medicinal chemistry. His patent and collaboration with esteemed colleagues reflect his commitment to innovation and research excellence.